MINNEAPOLIS - DiaMedica Therapeutics Inc. (NASDAQ:DMAC) will conduct an additional non-clinical study for its DM199 treatment in preeclampsia following a meeting with the U.S. Food and Drug ...
Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...
Voltage-gated K + (K V) channels regulate various physiological and pathophysiological processes and offer tremendous opportunities for the development of new drugs for cancer, autoimmune disease and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback